Alemtuzumab in the treatment of multiple sclerosis

Óscar Fernandez Institute of Clinical Neuroscience, Neurology Department, Hospital Regional Universitario Carlos Haya, FIMABIS, Malaga, Spain Abstract: Alemtuzumab (formerly known as Campath-1H) has recently been approved by the European Medicines Agency for highly-active, relapsing-remit...

Descrición completa

Gardado en:
Detalles Bibliográficos
Autor Principal: Fernandez &Oacute (Author)
Formato: Libro
Publicado: Dove Medical Press, 2014-02-01T00:00:00Z.
Subjects:
Acceso en liña:Connect to this object online.
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!